Consortium advancing cancer care for people with HIV
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11535254 · Data updated 2026-11-12
A national collaboration tests new cancer treatments and prevention strategies specifically for people living with HIV to reduce cancer-related illness and death.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $204,769 |
| NIH project number | 3UM1CA121947-20S6 |
| Project ID | NIH-11535254 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV who are at risk for or have AIDS-related cancers, and who may participate in clinical trials or related translational research.
✕Less likely to help
If a participant’s cancer type or condition isn’t part of an active trial, direct benefits may be limited.
What this research studies
The AIDS Malignancy Consortium brings multiple clinical sites together to run trials and studies focused on cancers that affect people with HIV. It aims to uncover new treatment and prevention options and to understand how these cancers develop in PLWH, so care guidelines can improve worldwide. The program collaborates with scientists, clinicians, and community advocates to ensure research meets patient needs and reaches LMICs with high HIV burdens.
Why it matters
Potential benefit: Could lead to better cancer prevention and treatment options for people living with HIV.
How similar studies have gone: Past AMC trials have shaped guidelines and advanced care for AIDS-related cancers in diverse settings.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.